Noninferiority of 6 Versus 12 Months of Dual Antiplatelet Therapy

被引:1
|
作者
Kaneda, Hideaki [1 ]
机构
[1] Okinaka Mem Inst Med Res, Tokyo 1058470, Japan
关键词
D O I
10.1016/j.jacc.2015.02.069
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2359 / 2359
页数:1
相关论文
共 50 条
  • [1] REPLY: Noninferiority of 6 Versus 12 Months of Dual Antiplatelet Therapy SECURITY Did Not Establish Noninferiority
    Colombo, Antonio
    Chieffo, Alaide
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (21) : 2360 - 2361
  • [2] Mortality and cancer after 12 versus 30 months dual antiplatelet therapy
    Serebruany, Victor L.
    Kim, Moo Hyun
    Cabrera-Fuentes, Hector A.
    Lee, Kwangmin
    Cho, Young Rak
    Park, Kyungil
    Park, Tae Ho
    Kim, Young Dae
    Yoon, Sung-Cheol
    [J]. THROMBOSIS AND HAEMOSTASIS, 2017, 117 (05) : 934 - 939
  • [3] After drug-eluting stent placement, 6 months of dual antiplatelet therapy was noninferior to 12 months
    Mukherjee, Debabrata
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 162 (08)
  • [4] Dual antiplatelet therapy beyond 12 months versus for 12 months after drug-eluting stents for acute myocardial infarction
    Sim, Doo Sun
    Jeong, Myung Ho
    Kim, Hyo Soo
    Gwon, Hyeon Cheol
    Seung, Ki Bae
    Rha, Seung Woon
    Chae, Shung Chull
    Kim, Chong Jin
    Cha, Kwang Soo
    Park, Jong Seon
    Yoon, Jung Han
    Chae, Jei Keon
    Joo, Seung Jae
    Choi, Dong Ju
    Hur, Seung Ho
    Seong, In Whan
    Cho, Myeong Chan
    Kim, Doo Il
    Oh, Seok Kyu
    Ahn, Tae Hoon
    Hwang, Jin Yong
    [J]. JOURNAL OF CARDIOLOGY, 2020, 75 (01) : 66 - 73
  • [5] DUAL ANTIPLATELET THERAPY FOR 1 TO 3 MONTHS IS SUPERIOR TO 12 MONTHS AFTER CORONARY STENTING
    Knijnik, Leonardo Mees
    Fernandes, Marcelo
    Cardoso, Rhanderson
    Montanez-Valverde, Raul
    Maza, Manuel Rivera
    Goyal, Abhinav
    Liberman, Henry
    Cohen, Mauricio
    Sperling, Laurence
    McDaniel, Michael
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1071 - 1071
  • [6] Shorter (≤6 Months) Versus Longer (≥12 Months) Duration Dual Antiplatelet Therapy After Drug Eluting Stents: A Meta-Analysis of Randomized Clinical Trials
    Pandit, Anil
    Giri, Smith
    Hakim, Fayaz Ahmad
    Fortuin, F. David
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2015, 85 (01) : 34 - 40
  • [7] Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE)
    Schuepke , Stefanie
    Mehilli, Julinda
    Laugwitz, Karl-Ludwig
    Neumann, Franz-Josef
    ten Berg, Jurrien M.
    Adriaenssens, Tom
    Han, Yaling
    von Merzljak, Barbara
    Richardt, Gert
    Seyfarth, Melchior
    Tiroch, Klaus
    Morath, Tanja
    Maeng, Michael
    Zrenner, Bernhard
    Rifatov, Nonlag
    Jacobshagen, Claudius
    Mudra, Harald
    von Hodenberg, Eberhard Freiherr
    Woehrle, Jochen
    Kufner, Sebastian
    Hengstenberg, Christian
    Fischer, Marcus
    Schmidt, Martin
    Dotzer, Franz
    Ibrahim, Tareq
    Sick, Peter
    Nienaber, Christoph A.
    van 't Hof, Arnoud W.
    Kimura, Takeshi
    Witzenbichler, Bernhard
    Windecker, Stephan
    Schunkert, Heribert
    Kastrati, Adnan
    [J]. CIRCULATION, 2014, 130 (23) : 2106 - 2106
  • [8] The Effectiveness of 6 versus 12 Months of Dialectical Behavior Therapy for Borderline Personality Disorder: A Noninferiority Randomized Clinical Trial
    McMain, Shelley F.
    Chapman, Alexander L.
    Kuo, Janice R.
    Dixon-Gordon, Katherine L.
    Guimond, Timothy Henry
    Labrish, Cathy
    Isaranuwatchai, Wanrudee
    Streiner, David L.
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2022, 91 (06) : 382 - 397
  • [10] ANALYSIS OF PLATELET HEMOSTASIS IN PATIENTS ON THE BACKGROUND OF DUAL ANTIPLATELET THERAPY FOR 12 MONTHS
    Kozachyshyn, Nataliia
    Netiazhenko, Vasyl
    Plenova, Olga
    Malchevska, Tetyana
    [J]. ATHEROSCLEROSIS, 2024, 395